Lupin has launched a generic version of Ravicti (Glycerol Phenylbutyrate) in the U.S. for urea cycle disorders. This medication is for patients who cannot solely rely on dietary restrictions. Shares ...

1 in 5 people with prostate cancer are diagnosed after their cancer has spread beyond the prostate, making the chance of cure low. Despite improvements in the treatment of advanced prostate cancer, ...

Drug firm Lupin on Friday said it has launched a generic medication to treat urea cycle disorders in the US. The company has launched an authorised generic version of Ravicti (Glycerol Phenylbutyrate) ...

Lysinuric protein intolerance (LPI) is an autosomal recessive disorder caused by variants in the SLC7A7 gene, leading to impaired transport of dibasic amino acids across intestinal and renal membranes ...

Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...

RCF, NFL and Indian Potash Ltd sign NDAs with Russian firms; proposed 2-million-tonne unit to reduce price volatility and import dependence. India is preparing to set up its first urea manufacturing ...

Our high-resolution metagenomic map shows a dramatic functional shift toward inflammation and metabolic imbalance, a loss of ...

Microsoft Edge is pretty good at being a PDF reader. If you are interested in basic reading, then Edge will suffice. That being said, Windows is all about the freedom of deciding what you want to use, ...